| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4634561
Max Phase: Preclinical
Molecular Formula: C17H14N2O5
Molecular Weight: 326.31
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: O=C(NO)c1cn(Cc2cc(O)cc(O)c2)c2ccccc2c1=O
Standard InChI: InChI=1S/C17H14N2O5/c20-11-5-10(6-12(21)7-11)8-19-9-14(17(23)18-24)16(22)13-3-1-2-4-15(13)19/h1-7,9,20-21,24H,8H2,(H,18,23)
Standard InChI Key: WNQVGQLBNIPINC-UHFFFAOYSA-N
Associated Targets(non-human)
Aldose reductase 4007 Activities
Aldehyde reductase 126 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 326.31 | Molecular Weight (Monoisotopic): 326.0903 | AlogP: 1.58 | #Rotatable Bonds: 3 |
| Polar Surface Area: 111.79 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.74 | CX Basic pKa: 0.01 | CX LogP: 1.68 | CX LogD: 1.66 |
| Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.43 | Np Likeness Score: -0.55 |
References
| 1. Han Z, Zhu J, Zhang Y, Zhang Y, Zhang H, Qi G, Zhu C, Hao X.. (2020) Novel quinolin-4(1H)-one derivatives as multi-effective aldose reductase inhibitors for treatment of diabetic complications: Synthesis, biological evaluation, and molecular modeling studies., 30 (9): [PMID:32192796] [10.1016/j.bmcl.2020.127101] |
Source
Source(1):